Entries by admin

SiChem sponsors the “Chemical Biology and Physiology Conference 2019” in Portland

The conference will take place from 12th to 15th of December at the Oregeon Health and Science University (OHSU) in Portland, USA. This biennial international conference focuses on the growing intersection of chemical biology and physiology. This exciting field offers innovative opportunities for the development of drug targets and therapy concepts. Leading scientists from all […]

CPhI in Frankfurt

We will be at the CPhI in Frankfurt on November 6th and we still have available dates – if you  like to meet us, just send us an e-mail and let us know when you will be available (info@sichem.de).

SiChem sponsors GFPP Meeting in Paris

From Monday 21st to Tuesday 22nd October 2019 the Symposium of  Noncanonical amino acids – Tools for biological and biophysical investigations will be held in Paris. It is co-organized with the French Peptides and Proteins Group (GFPP) This international symposium will focus on the emergent use of noncanonical amino acids (ncAAs) in peptide and protein science. […]

SiChem congratulates the Nobel Laureates

SiChem congratulates the Nobel Laureates in Chemistry Frances H. Arnold (California Institute of Technology / Caltech), George P. Smith (University of Missouri), and Gregory Winter (MRC Laboratory of Molecular Biology). Smith (University of Missouri), and Gregory Winter (MRC Laboratory of Molecular Biology). SiChem provides all 3 institutes with its useful tools for biochemical research.

Rapidly reversible Chemical Dimerizer rCD1 is now available at SiChem

The first rapidly reversible chemical dimerization system – rCD1 – , which permits to determine kinetics of lipid metabolizing enzymes in living cells, is now available at SiChem . This new system was applied to induce and stop the activity of phosphatidyl 3-kinase (PI3K) (SC-7000_Chemical_Dimerizer_info). rCD1 is available in 2 sizes: 100µg (for app. 20 […]

INO-4995 has potential in treatment of Cystic Fibrosis (CF)

INO-4995 (1-O-octyl-2-O-butyryl-D-myo-inositol 3,4,5,6-tetrakisphosphate octakis(propionoxymethyl)ester) is an ion channel modulator that is slowly metabolized in cells. Studies have shown that it inhibits ENaC activity while promoting expression of the calcium-activated chloride channel, TMEM16a, in membranes. Thus it has potential therapeutic activity in the treatment of cystic fibrosis where it normalized nasal potential difference (npd) in a […]